{"id":1636,"date":"2016-05-30T05:16:36","date_gmt":"2016-05-30T05:16:36","guid":{"rendered":"http:\/\/zestmag.com\/online\/?p=1636"},"modified":"2016-05-30T05:16:36","modified_gmt":"2016-05-30T05:16:36","slug":"new-alzheimer-study-takes-a-closer-look-at-abeta","status":"publish","type":"post","link":"http:\/\/zestmag.com\/online\/new-alzheimer-study-takes-a-closer-look-at-abeta\/","title":{"rendered":"New Alzheimer study takes a closer look at ABeta"},"content":{"rendered":"<section class=\"release-body container  no-margin-bottom \">\n<div class=\"section-divider\">\n<div class=\"row\">\n<div class=\"col-sm-10 col-sm-offset-1\">\n<p><strong>A key protein found in the brain of Alzheimer&#8217;s disease patients is related to the body&#8217;s innate immune system \u2013 raising new questions about the role of infection in Alzheimer&#8217;s disease, according to research published in <i>Science Translational Medicine<\/i> and funded by Cure Alzheimer&#8217;s Fund.<\/strong><\/p>\n<p><a href=\"http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1637\" src=\"http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer.jpg\" alt=\"alzheimer\" width=\"620\" height=\"445\" srcset=\"http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer.jpg 620w, http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer-300x215.jpg 300w, http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer-50x35.jpg 50w, http:\/\/zestmag.com\/online\/wp-content\/uploads\/2016\/05\/alzheimer-107x77.jpg 107w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\" \/><\/a><\/p>\n<p>The protein, ABeta (A\u03b2), makes up the \u03b2-amyloid plaques in the brain associated with Alzheimer&#8217;s patients. The study suggests that A\u03b2 is an antimicrobial peptide, a critically important protein that acts as a natural antibiotic in the immune system. The study raises new implications about the potential role of pathogens in Alzheimer&#8217;s disease, and potential avenues for treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section class=\"release-body container  no-margin-bottom \">\n<div class=\"row\">\n<div class=\"col-sm-10 col-sm-offset-1\">\n<p>The findings are detailed in a new paper, &#8220;Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer&#8217;s disease,&#8221; co-authored by <span class=\"xn-person\">Robert Moir<\/span>, PhD., assistant professor of neurology at Harvard Medical Center and Massachusetts General Hospital Neurology Research, and <span class=\"xn-person\">Rudolph Tanzi<\/span>, PhD., <i>Vice-Chair of Neurology and Director of the Genetics and Aging Research Unit at MGH and Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School.\u00a0 Dr. Tanzi is the Chair of the Cure Alzheimer&#8217;s Fund Research Consortium.<\/i><\/p>\n<p>&#8220;A\u03b2 was previously thought to be intrinsically pathological, but our findings suggest it is actually designed to protect the brain,&#8221; said Dr. Moir. &#8220;Because of A\u03b2&#8217;s role as part of the innate immune system, researchers may need to more carefully consider infection as a possible environmental factor leading to the development of Alzheimer&#8217;s.&#8221;<\/p>\n<p>In the study, human A\u03b2 protected against otherwise lethal infections in mice, nematode worms and cultured neuronal cells.\u00a0 In addition, A\u03b2 generation appears to have a protective physiological role, entrapping invading pathogens in a degradation-resistant protein matrix.<\/p>\n<p>The findings support a new anti-microbial protection hypothesis: Alzheimer&#8217;s disease may arise when the brain perceives itself to be under attack from invading pathogens and launches amyloid formation. Additional study is needed to determine whether A\u03b2 is responding to actual or perceived infection in the brains of Alzheimer&#8217;s patients.<\/p>\n<p>As people age and their adaptive immune system changes, they may become more susceptible to pathogens that enter the body.<\/p>\n<p>The study may also have implications for Alzheimer&#8217;s therapies currently in development, which are largely based upon the premise that A\u03b2 is pathological. Instead of eradicating amyloid from the brains of Alzheimer&#8217;s patients, a safer approach may be therapies that are designed to lower amyloid levels without destroying them entirely.<\/p>\n<p>&#8220;The finding of an innate immune role for A\u03b2 activities shows a clear and urgent need to review the assumptions currently guiding efforts to develop treatments for this terrible disease,&#8221; said Dr. Tanzi.<\/p>\n<p>The study, which was published online in <i>Science Translational Medicine, <\/i>was funded by Cure Alzheimer&#8217;s Fund and the National Institute on Aging.\u00a0 Cure Alzheimer&#8217;s Fund provided <span class=\"xn-money\">$1.6 million<\/span> in funding, made possible in part by a grant from the Helmsley Foundation.<\/p>\n<p>&#8220;This research offers a major paradigm shift when it comes to A\u03b2 and the important role it plays in the immune system,&#8221; said<span class=\"xn-person\">Timothy Armour<\/span>, president and CEO of Cure Alzheimer&#8217;s Fund. &#8220;Not only do these findings raise questions about the potential causes of Alzheimer&#8217;s, but they generate new avenues of inquiry into the therapies that may best target the disease.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>The study may also have implications for Alzheimer&#8217;s therapies currently in development, which are largely based upon the premise that A\u03b2 is pathological. Instead of eradicating amyloid from the brains of Alzheimer&#8217;s patients, a safer approach may be therapies that are designed to lower amyloid levels without destroying them entirely. <\/p>\n","protected":false},"author":3,"featured_media":1638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,3,35],"tags":[922,921,19,20],"class_list":["post-1636","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-wellness-2","category-spotlight","category-wellness-2","tag-abeta","tag-alzheimers-disease","tag-health","tag-wellness"],"_links":{"self":[{"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/comments?post=1636"}],"version-history":[{"count":1,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1636\/revisions"}],"predecessor-version":[{"id":1639,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/posts\/1636\/revisions\/1639"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/media\/1638"}],"wp:attachment":[{"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/media?parent=1636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/categories?post=1636"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/zestmag.com\/online\/wp-json\/wp\/v2\/tags?post=1636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}